Tonix Pharmaceuticals Holding Corp. (TNXP) Form 8-K — Aug 18, 2026

$TNXPForm 8-KItems 5.02, 8.01Filed Aug 18, 2026, 4:00 PM ET0001493152-26-039000Original filing

Tonix Pharmaceuticals Holding Corp. disclosed in an 8-K that on August 18, 2026 its Board of Directors appointed Dr. Seth Lederman, the company's President and Chief Executive Officer, as Interim Chief Medical Officer. Dr.

Key figures

Lederman Age: 69
Roles Combined: ["President","Chief Executive Officer","Chairman of the Board","Interim Chief Medical Officer"]
Lederman Tenure Since: October 2011

Price after filing

1 day: +0.6%7 days: +7.9%30 days: -9.8%

Close on the filing date to close N calendar days later (from $12.66). Historical, not a forecast.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.